Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.
This report elaborates on the current development of the Biologics and Biosimilars industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Roche
CP Guojian
Johnson & Johnson
Merck
Novo Nordisk
Amgen
Sanofi-Aventis
Changchun High Tech
Novartis
AbbVie
Innovent
Eli Lilly
Ganlee
Dong Bao
3sbio
Pfizer
Biotech
Gelgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Application:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biologics and Biosimilars Industry Overview
-
1.1.1 Biologics and Biosimilars Market Scope and Market Segments
-
1.1.2 Biologics and Biosimilars Industry Characteristics
-
1.1.3 Global and China Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biologics and Biosimilars Production Value and Growth Rate (2017-2028)
-
1.2 Global Biologics and Biosimilars Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monoclonal Antibodies
-
1.2.2 Interferon
-
1.2.3 Erythropoietin
-
1.2.4 Insulin
-
1.2.5 Vaccines
-
1.2.6 Other
-
1.3 Global Biologics and Biosimilars Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Tumor
-
1.3.2 Diabetes
-
1.3.3 Cardiovascular
-
1.3.4 Hemophilia
-
1.3.5 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biologics and Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biologics and Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biologics and Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biologics and Biosimilars Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biologics and Biosimilars Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biologics and Biosimilars Industry Porter's Five Forces Model Analysis
-
2.2.3 Biologics and Biosimilars Industry PEST Analysis
-
2.3 Biologics and Biosimilars Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biologics and Biosimilars Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biologics and Biosimilars Industry
Chapter 3 Global and China Biologics and Biosimilars Market, by Manufacturer
-
3.1 Global and China Biologics and Biosimilars Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biologics and Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biologics and Biosimilars Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biologics and Biosimilars Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biologics and Biosimilars Market Top 3 Players
Chapter 4 Global and China Biologics and Biosimilars Market, by Type (2017-2028)
-
4.1 Biologics and Biosimilars Market Trend, by Type
-
4.2 Global Biologics and Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biologics and Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biologics and Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biologics and Biosimilars Price Trend, by Type (2017-2028)
-
4.3 China Biologics and Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biologics and Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biologics and Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biologics and Biosimilars Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biologics and Biosimilars Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biologics and Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biologics and Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biologics and Biosimilars Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biologics and Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biologics and Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biologics and Biosimilars Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biologics and Biosimilars Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biologics and Biosimilars Market Analysis
-
7.1 North America Biologics and Biosimilars Market, by Type
-
7.2 North America Biologics and Biosimilars Market, by Application
-
7.3 North America Biologics and Biosimilars Market Analysis and Forecast, by Country
-
7.3.1 United States Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biologics and Biosimilars Market Analysis
-
8.1 Europe Biologics and Biosimilars Market, by Type
-
8.2 Europe Biologics and Biosimilars Market, by Application
-
8.3 Europe Biologics and Biosimilars Market Analysis and Forecast, by Country
-
8.3.1 Germany Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biologics and Biosimilars Market Analysis
-
9.1 APAC Biologics and Biosimilars Market, by Type
-
9.2 APAC Biologics and Biosimilars Market, by Application
-
9.3 APAC Biologics and Biosimilars Market Analysis and Forecast, by Country
-
9.3.1 China Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biologics and Biosimilars Market Analysis
-
10.1 Latin America, Middle East and Africa Biologics and Biosimilars Market, by Type
-
10.2 Latin America, Middle East and Africa Biologics and Biosimilars Market, by Application
-
10.3 Latin America, Middle East and Africa Biologics and Biosimilars Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biologics and Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biologics and Biosimilars Company Profiles
-
11.1 Roche
-
11.1.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Roche Biologics and Biosimilars Product Profiles, Application and Specification
-
11.1.3 Roche Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 CP Guojian
-
11.2.1 CP Guojian Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 CP Guojian Biologics and Biosimilars Product Profiles, Application and Specification
-
11.2.3 CP Guojian Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Johnson & Johnson
-
11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Johnson & Johnson Biologics and Biosimilars Product Profiles, Application and Specification
-
11.3.3 Johnson & Johnson Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Merck
-
11.4.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Merck Biologics and Biosimilars Product Profiles, Application and Specification
-
11.4.3 Merck Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Novo Nordisk
-
11.5.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Novo Nordisk Biologics and Biosimilars Product Profiles, Application and Specification
-
11.5.3 Novo Nordisk Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Amgen
-
11.6.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Amgen Biologics and Biosimilars Product Profiles, Application and Specification
-
11.6.3 Amgen Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Sanofi-Aventis
-
11.7.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Sanofi-Aventis Biologics and Biosimilars Product Profiles, Application and Specification
-
11.7.3 Sanofi-Aventis Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Changchun High Tech
-
11.8.1 Changchun High Tech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Changchun High Tech Biologics and Biosimilars Product Profiles, Application and Specification
-
11.8.3 Changchun High Tech Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Novartis
-
11.9.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Novartis Biologics and Biosimilars Product Profiles, Application and Specification
-
11.9.3 Novartis Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 AbbVie
-
11.10.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 AbbVie Biologics and Biosimilars Product Profiles, Application and Specification
-
11.10.3 AbbVie Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Innovent
-
11.11.1 Innovent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Innovent Biologics and Biosimilars Product Profiles, Application and Specification
-
11.11.3 Innovent Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Eli Lilly
-
11.12.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Eli Lilly Biologics and Biosimilars Product Profiles, Application and Specification
-
11.12.3 Eli Lilly Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Ganlee
-
11.13.1 Ganlee Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Ganlee Biologics and Biosimilars Product Profiles, Application and Specification
-
11.13.3 Ganlee Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Dong Bao
-
11.14.1 Dong Bao Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Dong Bao Biologics and Biosimilars Product Profiles, Application and Specification
-
11.14.3 Dong Bao Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 3sbio
-
11.15.1 3sbio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 3sbio Biologics and Biosimilars Product Profiles, Application and Specification
-
11.15.3 3sbio Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Pfizer
-
11.16.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Pfizer Biologics and Biosimilars Product Profiles, Application and Specification
-
11.16.3 Pfizer Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Biotech
-
11.17.1 Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Biotech Biologics and Biosimilars Product Profiles, Application and Specification
-
11.17.3 Biotech Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Gelgen
-
11.18.1 Gelgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Gelgen Biologics and Biosimilars Product Profiles, Application and Specification
-
11.18.3 Gelgen Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biologics and Biosimilars Industry Investment Prospect and Risk Assessment
-
12.1 Biologics and Biosimilars Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biologics and Biosimilars Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biologics and Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure China Biologics and Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Interferon (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Erythropoietin (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Insulin (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Vaccines (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Tumor (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Diabetes (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Cardiovascular (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Hemophilia (2017-2028)
-
Figure Global Biologics and Biosimilars Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics and Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biologics and Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biologics and Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biologics and Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biologics and Biosimilars Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biologics and Biosimilars Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biologics and Biosimilars Market Share, by Manufacturer in 2021
-
Figure Global and China Biologics and Biosimilars Market Share, by Manufacturer in 2022
-
Table Global Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table Global Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Global Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Global Biologics and Biosimilars Sales Value, by Type (2017-2028)
-
Table Global Biologics and Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure Global Biologics and Biosimilars Price Trend, by Type (2017-2028)
-
Table China Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table China Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure China Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table China Biologics and Biosimilars Sales Value, by Type (2017-2028)
-
Table China Biologics and Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure China Biologics and Biosimilars Price Trend, by Type (2017-2028)
-
Table Global Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table Global Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Global Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table Global Biologics and Biosimilars Sales Value, by Application (2017-2028)
-
Table Global Biologics and Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure Global Biologics and Biosimilars Sales Value Share, by Application (2017-2028)
-
Table China Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table China Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table China Biologics and Biosimilars Sales Value, by Application (2017-2028)
-
Table China Biologics and Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biologics and Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biologics and Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Table North America Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table North America Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure North America Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table North America Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table North America Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure North America Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure United States Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Europe Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table Europe Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Europe Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table Europe Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure UK Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure France Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure France Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table APAC Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table APAC Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table APAC Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table APAC Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure India Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure India Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics and Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biologics and Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biologics and Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CP Guojian Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CP Guojian Product Profiles, Application and Specification
-
Table CP Guojian Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi-Aventis Product Profiles, Application and Specification
-
Table Sanofi-Aventis Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Changchun High Tech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Changchun High Tech Product Profiles, Application and Specification
-
Table Changchun High Tech Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Innovent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Innovent Product Profiles, Application and Specification
-
Table Innovent Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ganlee Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ganlee Product Profiles, Application and Specification
-
Table Ganlee Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dong Bao Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dong Bao Product Profiles, Application and Specification
-
Table Dong Bao Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table 3sbio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table 3sbio Product Profiles, Application and Specification
-
Table 3sbio Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biotech Product Profiles, Application and Specification
-
Table Biotech Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gelgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gelgen Product Profiles, Application and Specification
-
Table Gelgen Biologics and Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
